Europe Biofilms Treatment Market Forecast to 2027 – COVID-19 Impact and Analysis – By Product (Debridement Equipment, Gauzes and Dressings, Grafts and Matrices, and Others); Wound (Traumatic and Surgical Wounds, Diabetic Foot Ulcers, Pressure Ulcers, Venous Leg Ulcers, and Others); End User (Hospitals, Home Care Settings, and Others); and Country
Pages: 131
Market Introduction
Biofilms are composed of mixed strains of fungi, bacteria, yeasts, algae, and other microbes. A biofilm develops on the wound surface when certain types of bacteria or fungi adhere to the wound surface and form a matrix over it. A viscous and shiny substance with unpleasant smell are secreted. Growing number of traumatic, sports injuries, coupled with increasing prevalence of obesity are anticipated to drive the market growth during the forecast period.
Market Overview and Dynamics
The Europe biofilms treatment market is expected to reach US$ 833.61million in 2027 from US$ 454.60million in 2019. The market is estimated to grow with a CAGR of 7.9% from 2020-2027. The growth of this market is estimated to grow owing to key driving factors such as the rising prevalence of diabetes and associated illnesses and growing incidences of pressure ulcers and traumatic wounds. However, the market is expected experiencing slow growth during the forecast period owing to multi-drugs resistance problem associated with biofilms treatment.
Key Market Segments
Based on product, the biofilms treatment market is segmented into debridement equipment, gauzes and dressings, grafts and matrices, and others. Based on wound, the biofilms treatment market is segmented into traumatic and surgical wounds, diabetic foot ulcers, pressure ulcers, venous leg ulcers, and others. Based on end-user, the biofilms treatment market, is segmented into hospitals, home care settings, and others.
Major Sources and Companies Listed
Some of the major primary and secondary sources for biofilms treatment market included in the report are German Diabetes Society (DDG), National Health Survey (UK), European Wound Management Association (EWMA), and others.
Reasons to buy the report
- To understand the Europe biofilms treatment market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for biofilms treatment market
- Efficiently plan M&A and partnership deals in Europe biofilms treatment market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form biofilms treatment market
- Obtain market revenue forecast for market by various segments from 2019 to 2027 in Europe region
EUROPE BIOFILMS TREATMENT MARKET SEGMENTATION
By Product
- Traumatic and Surgical Wounds
- Diabetic Foot Ulcers
- Pressure Ulcers
- Venous Leg Ulcers
- Others
- Hospitals
- Home Care Settings
- Others
By Country
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
Company Profiles
- Smith & Nephew
- MiMedx
- ConvaTec Group Plc
- Coloplast Group
- Mölnlycke Health Care AB.
- Organogenesis Inc.
- Integra Life Sciences Corporation
- B. Braun Melsungen AG
- Hartman Group
- Medline Industries, Inc.
Europe Biofilms Treatment Market Strategic Insights
Europe Biofilms Treatment Market Report Highlights
| Report Attribute | Details |
| Market size in 2019 | US$ 454.60 Million |
| Market Size by 2027 | US$ 833.61 Million |
| CAGR (2020 - 2027) | 7.9% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Product
|
|
Regions and Countries Covered
|
|
| Europe | UK, Germany, France, Russia, Italy, Rest of Europe |
| Market leaders and key company profiles |
|
Europe Biofilms Treatment Market Country and Regional Insights
